Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-003179
Filing Date
2025-02-05
Accepted
2025-02-05 21:23:25
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 form4-02062025_020220.html 4  
1 form4-02062025_020220.xml 4 41320
  Complete submission text file 0001415889-25-003179.txt   42795
Mailing Address C/O NEON THERAPEUTICS 40 ERIE STREET, SUITE 110 CAMBRIDGE MA 02139
Business Address
ANG ROBERT (Reporting) CIK: 0001741283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 25595157

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)